Cost-effectiveness of Tele-expertise for Premature Infants for Retinopathy

Effectiveness and Cost-effectiveness of Tele-expertise for the Screening Examination of Premature Infants for Retinopathy of Prematurity

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02157727

Acronym

Dite-ROP

Enrollment

843

Registered

2014-06-06

Start date

2014-01-31

Completion date

2015-10-31

Last updated

2015-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinopathy of Prematurity

Brief summary

The purpose of this study is to determine whether telemedicine would be as effective as having a pediatrics ophthalmologist on site for screening examination of retinopathy in premature infants and would be cost-effective.

Interventions

DEVICEInfants hospitalized in health facilities performing Tele-expertise

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Born before 32 WA or having a birth weight under 1500g

Exclusion criteria

* Brain malformations

Design outcomes

Primary

Measure	Time frame	Description
Proportion of premature infants being screened for retinopathy following recommendations	4 weeks in average	Proportion of premature infants being screened for retinopathy following recommendations (between 31 and 32 weeks of amenorrhea (WA) for infants born before 28 WA and during the fourth week of life for infants born after 28 WA)

Secondary

Measure	Time frame	Description
Delay before the first screening of retinopathy	4 weeks in average	For infants born at or after 28WA
Cost of telemedicine	6 months after enrollment of the first patient	—

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026